共 2 条
[1]
Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study[J] . W. Eiermann,S. Paepke,J. Appfelstaedt,A. Llombart-Cussac,J. Eremin,J. Vinholes,L. Mauriac,M. Ellis,M. Lassus,H. A. Chaudri-Ross,M. Dugan,M. Borgs,V. Semiglazov.Annals of Oncology . 2001 (11)
[2]
Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate. Dombernowsky P, Smith I, Falkson G, et al. Journal of Clinical Oncology . 1998